Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anastasios Stathis

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
Biorxiv : the Preprint Server for Biology|July 14, 2025
IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomasAlberto J Arribas, Francesca Guidetti, Eleonora Cannas, et al.
Hematological Oncology|June 22, 2025
Primary Extranodal Follicular Lymphoma: A Retrospective Survey of the International Extranodal Lymphoma Study Group (IELSG)Annarita Conconi, Andrea Janikova, Barbara Vannata, et al.
Blood Advances|August 22, 2025
Pirtobrutinib, a Highly Selective, Non-covalent (Reversible) BTKi in R/R Follicular Lymphoma: Phase 1/2 BRUIN StudyNirav N Shah, Pier Luigi Zinzani, Michael L Wang, et al.
Blood|May 29, 2026
IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomasAlberto J Arribas, Eleonora Cannas, Giulio Sartori, et al.
Blood|February 17, 2018
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphomaValeria Spina, Alessio Bruscaggin, Annarosa Cuccaro, et al.
Blood|September 12, 2025
Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trialEmanuele Zucca, Luca Ceriani, Giovannino Ciccone, et al.
Haematologica|June 20, 2024
A first-in-class Wiskott-Aldrich syndrome protein activator with antitumor activity in hematologic cancersFilippo Spriano, Giulio Sartori, Jacopo Sgrignani, et al.
Haematologica|February 22, 2024
IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphomaAnastasios Stathis, Maria Cristina Pirosa, Lorella Orsucci, et al.
Nature|October 16, 2023
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistanceChristina Guo, Adam Sharp, Bora Gurel, et al.
Blood|May 13, 2025
A Comprehensive Genetic Study of Classical Hodgkin Lymphoma Using Circulating Tumor DNAMaria Cristina Pirosa, Alessio Bruscaggin, Lodovico Terzi di Bergamo, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Biorxiv : the Preprint Server for Biology|July 14, 2025
IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomasAlberto J Arribas, Francesca Guidetti, Eleonora Cannas, et al.
Hematological Oncology|June 22, 2025
Primary Extranodal Follicular Lymphoma: A Retrospective Survey of the International Extranodal Lymphoma Study Group (IELSG)Annarita Conconi, Andrea Janikova, Barbara Vannata, et al.
Blood Advances|August 22, 2025
Pirtobrutinib, a Highly Selective, Non-covalent (Reversible) BTKi in R/R Follicular Lymphoma: Phase 1/2 BRUIN StudyNirav N Shah, Pier Luigi Zinzani, Michael L Wang, et al.
Blood|May 29, 2026
IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomasAlberto J Arribas, Eleonora Cannas, Giulio Sartori, et al.
Blood|February 17, 2018
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphomaValeria Spina, Alessio Bruscaggin, Annarosa Cuccaro, et al.
Blood|September 12, 2025
Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trialEmanuele Zucca, Luca Ceriani, Giovannino Ciccone, et al.
Haematologica|June 20, 2024
A first-in-class Wiskott-Aldrich syndrome protein activator with antitumor activity in hematologic cancersFilippo Spriano, Giulio Sartori, Jacopo Sgrignani, et al.
Haematologica|February 22, 2024
IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphomaAnastasios Stathis, Maria Cristina Pirosa, Lorella Orsucci, et al.
Nature|October 16, 2023
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistanceChristina Guo, Adam Sharp, Bora Gurel, et al.
Blood|May 13, 2025
A Comprehensive Genetic Study of Classical Hodgkin Lymphoma Using Circulating Tumor DNAMaria Cristina Pirosa, Alessio Bruscaggin, Lodovico Terzi di Bergamo, et al.
Pageof 14